This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Chewy Stock Up 23% in a Month: Is it Time to Buy, Hold or Cash Out?
by Sumit Singh
Chewy has firmed its position in online pet retail, leveraging its Autoship program and expanding veterinary services to drive growth and long-term stability.
Is Central Garden & Pet Stock Hold or Sell Post Q3 Earnings?
by Zacks Equity Research
CENT is grappling with weak performance in its Pet and Garden segments, compounded by shifts in consumer demand.
Central Garden (CENT) Down 3.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CENT Stock Declines 11% in 3 Months: Should You Buy, Hold or Sell?
by Zacks Equity Research
Central Garden & Pet Company is facing softness in new pet adoptions as well as lower foot traffic at home center retailers.
Is Chewy (CHWY) Stock a Wise Investment Ahead of Q2 Earnings?
by Sumit Singh
Chewy's (CHWY) strategic focus on expanding its product offerings and enhancing customer experience is likely to have favorably impacted second-quarter earnings.
New Strong Sell Stocks for August 22nd
by Zacks Equity Research
BW, CENT and KOF have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2024.
Central Garden & Pet (CENT) Q3 Earnings Beat, Organic Sales Fall
by Zacks Equity Research
Central Garden & Pet's (CENT) third-quarter results reflect a net sales decline of 6.1% in the Garden segment. Nonetheless, the company has been containing costs and simplifying its portfolio.
Central Garden (CENT) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 5.60% and 1.14%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Alto Ingredients (ALTO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alto Ingredients (ALTO) delivered earnings and revenue surprises of 54.55% and 0.13%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Central Garden (CENT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Central Garden (CENT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 22nd
by Zacks Equity Research
BAMXF, BOH and CENT have been added to the Zacks Rank #5 (Strong Sell) List on July 22, 2024.
Zacks Industry Outlook Reynolds, Central Garden & Pet, The Honest and Lifetime Brands
by Zacks Equity Research
Reynolds, Central Garden & Pet, The Honest and Lifetime Brands have been highlighted in this Industry Outlook article.
4 Stocks to Watch in a Promising Consumer Products-Discretionary Industry
by Sumit Singh
Reynolds (REYN), Central Garden & Pet (CENT), The Honest Company (HNST) and Lifetime Brands (LCUT) focus on a superior product strategy and prudent capital investments.
Central Garden (CENT) Down 8.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Central Garden & Pet (CENT) Q2 Earnings Beat, Margins Expand
by Zacks Equity Research
Central Garden & Pet's (CENT) second-quarter results reflect a net sales increase of 1.1% in the Pet segment. The company has been containing costs and simplifying the business.
Central Garden (CENT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Central Garden (CENT) delivered earnings and revenue surprises of 19.28% and 0.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Wynn Resorts (WYNN) Stock Ahead of Q1 Earnings?
by Zacks Equity Research
Wynn Resorts' (WYNN) first-quarter performance is likely to have benefited from an uptick in visitation and demand, particularly in the Las Vegas and Macau regions.
Weak Box Office to Dampen AMC Entertainment (AMC) Q1 Earnings
by Zacks Equity Research
AMC Entertainment's (AMC) first-quarter 2024 results are likely to witness a weakness in the box-office performance.
Here's How Spectrum Brands (SPB) is Poised Ahead of Q2 Earnings
by Zacks Equity Research
Spectrum Brands' (SPB) second-quarter fiscal 2024 results are likely to reflect gains from increased pricing, cost improvements and a favorable mix.
Here's How Aaron's (AAN) is Poised Just Ahead of Q1 Earnings
by Zacks Equity Research
Aaron's (AAN) first-quarter 2024 results are likely to reflect the impacts of sluggishness across its namesake business unit and a tough operating backdrop.
Can Crocs (CROX) Beat on Q1 Earnings Despite Cost Headwinds?
by Zacks Equity Research
Crocs' (CROX) Q1 results are likely to reflect the continued impacts of a challenging macro environment and higher HEYDUDE acquisition-related costs. Pricing actions and strong demand place it well.
Central Garden & Pet Company (CENT) Queued for Q2 Earnings
by Zacks Equity Research
Central Garden & Pet (CENT) faces challenges from deflation, changing consumer behavior and softer pet adoptions. However, the Garden segment is likely to showcase strength.
Why Central Garden & Pet (CENT) Might Surprise This Earnings Season
by Zacks Equity Research
Central Garden & Pet (CENT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's How Carter's (CRI) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
Carter's (CRI) first-quarter 2024 results are likely to reflect inflationary impacts and increased performance-based compensation provisions.
Earnings Preview: Kellanova (K) Q1 Earnings Expected to Decline
by Zacks Equity Research
Kellanova (K) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.